1.16
price down icon0.01%   -0.01
after-market 시간 외 거래: 1.16
loading
전일 마감가:
$1.17
열려 있는:
$1.15
하루 거래량:
51,618
Relative Volume:
1.02
시가총액:
$19.38M
수익:
-
순이익/손실:
$-52.53M
주가수익비율:
-0.2922
EPS:
-3.97
순현금흐름:
$-39.93M
1주 성능:
-7.15%
1개월 성능:
-16.44%
6개월 성능:
-19.87%
1년 성능:
-43.21%
1일 변동 폭
Value
$1.14
$1.17
1주일 범위
Value
$1.14
$1.2898
52주 변동 폭
Value
$1.105
$2.17

Unity Biotechnology Inc Stock (UBX) Company Profile

Name
명칭
Unity Biotechnology Inc
Name
전화
(650) 416-1192
Name
주소
285 EAST GRAND AVENUE, SOUTH SAN FRANCISCO, CA
Name
직원
19
Name
트위터
@unitybiotech
Name
다음 수익 날짜
2024-11-11
Name
최신 SEC 제출 서류
Name
UBX's Discussions on Twitter

UBX을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
UBX 1.16 19.38M 0 -52.53M -39.93M -3.97
VRTX 450.37 115.43B 10.63B -479.80M -1.35B 13.33
REGN 744.50 82.04B 13.85B 4.65B 3.32B 35.06
ARGX 596.74 35.30B 1.86B -40.29M -1.28B -4.16
ALNY 246.80 32.04B 2.09B -332.26M 16.06M -4.14
BNTX 108.23 24.89B 3.30B -501.07M 1.03B 11.54

Unity Biotechnology Inc Stock (UBX) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2022-01-04 업그레이드 ROTH Capital Neutral → Buy
2021-11-10 업그레이드 Mizuho Neutral → Buy
2021-06-28 업그레이드 Citigroup Sell → Buy
2021-06-07 개시 H.C. Wainwright Buy
2021-02-16 다운그레이드 Citigroup Neutral → Sell
2020-08-18 다운그레이드 Citigroup Buy → Neutral
2020-08-18 다운그레이드 Mizuho Buy → Neutral
2020-08-18 다운그레이드 Morgan Stanley Overweight → Equal-Weight
2020-08-17 다운그레이드 ROTH Capital Buy → Neutral
2020-07-28 개시 ROTH Capital Buy
2019-12-12 개시 Cantor Fitzgerald Overweight
2019-03-07 개시 Cantor Fitzgerald Overweight
2018-09-07 개시 Mizuho Buy
2018-05-29 개시 Citigroup Buy
2018-05-29 개시 Goldman Neutral
2018-05-29 개시 Morgan Stanley Overweight
모두보기

Unity Biotechnology Inc 주식(UBX)의 최신 뉴스

pulisher
Nov 19, 2024

Frazier Life Sciences Appoints John Smither and Jim Williams as Senior Advisors - BioSpace

Nov 19, 2024
pulisher
Nov 15, 2024

Alyeska Investment Group L.P.'s Strategic Acquisition in Unity B - GuruFocus.com

Nov 15, 2024
pulisher
Nov 07, 2024

Unity Biotechnology's CFO sells shares worth $175 - Investing.com India

Nov 07, 2024
pulisher
Nov 07, 2024

Unity Biotechnology's chief legal officer sells shares worth $192 - Investing.com

Nov 07, 2024
pulisher
Nov 06, 2024

Unity Biotechnology's CFO sells shares worth $175 By Investing.com - Investing.com Canada

Nov 06, 2024
pulisher
Nov 06, 2024

Unity Biotechnology's chief legal officer sells shares worth $192 By Investing.com - Investing.com Canada

Nov 06, 2024
pulisher
Nov 06, 2024

Unity Biotechnology stock hits 52-week low at $1.15 - Investing.com

Nov 06, 2024
pulisher
Nov 06, 2024

Unity Biotechnology CEO Anirvan Ghosh sells $557 in stock By Investing.com - Investing.com UK

Nov 06, 2024
pulisher
Nov 05, 2024

Unity Biotechnology stock hits 52-week low at $1.15 By Investing.com - Investing.com Canada

Nov 05, 2024
pulisher
Nov 05, 2024

Is Unity Biotechnology (NASDAQ:UBX) In A Good Position To Invest In Growth? - Simply Wall St

Nov 05, 2024
pulisher
Nov 04, 2024

Unity Biotechnology Focuses on Promising DME Treatment - TipRanks

Nov 04, 2024
pulisher
Nov 04, 2024

Dyadic to Report Third Quarter 2024 Financial Results on Tuesday, November 12, 2024 - The Manila Times

Nov 04, 2024
pulisher
Nov 04, 2024

UNITY Biotechnology, Inc. Reports Third Quarter 2024 Financial Results and Business Updates - GlobeNewswire

Nov 04, 2024
pulisher
Oct 22, 2024

Age-related Macular Degeneration Market Size is Set for Rapid - openPR

Oct 22, 2024
pulisher
Oct 16, 2024

Wet Age-Related Macular Degeneration Pipeline Therapeutics, Assessment, Companies, Products, Unmet Needs, Market Drivers and Barriers - The Globe and Mail

Oct 16, 2024
pulisher
Oct 16, 2024

Empery Asset Management LP Acquires Shares in Tonix Pharmaceuticals - Yahoo Finance UK

Oct 16, 2024
pulisher
Oct 11, 2024

First patient dosed at the Tokyo Medical Center by Belite Bio in Phase 2/3 DRAGON II clinical trial - Ophthalmology Times

Oct 11, 2024
pulisher
Oct 09, 2024

Empery Asset Management, LP Acquires Shares in Volcon Inc - Yahoo Finance UK

Oct 09, 2024
pulisher
Oct 09, 2024

Empery Asset Management's Strategic Acquisition in Elevation Oncology - Yahoo Finance

Oct 09, 2024
pulisher
Oct 09, 2024

Empery Asset Management's Strategic Reduction in Sharps Technology Inc - Yahoo Finance

Oct 09, 2024
pulisher
Oct 03, 2024

To Reverse Aging’s Clock, Adjust the Cell’s Machinery - Genetic Engineering & Biotechnology News

Oct 03, 2024
pulisher
Sep 24, 2024

UNITY Biotechnology to Host In-Person Ophthalmology Day in New York on Tuesday, October 15, 2024 - GlobeNewswire

Sep 24, 2024
pulisher
Sep 24, 2024

Unity Biotechnology (FRA:9U90) Cash Ratio : 3.85 (As of Jun. 2024) - GuruFocus.com

Sep 24, 2024
pulisher
Sep 23, 2024

Jefferies Financial Group Boosts United Therapeutics (NASDAQ:UTHR) Price Target to $432.00 - Defense World

Sep 23, 2024
pulisher
Sep 23, 2024

Tri Locum Partners LP Makes New Investment in United Therapeutics Co. (NASDAQ:UTHR) - MarketBeat

Sep 23, 2024
pulisher
Sep 22, 2024

Epoch Investment Partners Inc. Increases Stake in United Therapeutics Co. (NASDAQ:UTHR) - Defense World

Sep 22, 2024
pulisher
Sep 22, 2024

United Therapeutics Co. (NASDAQ:UTHR) Shares Acquired by Mercer Global Advisors Inc. ADV - Defense World

Sep 22, 2024
pulisher
Sep 22, 2024

Symmetry Investments LP Makes New Investment in United Therapeutics Co. (NASDAQ:UTHR) - Defense World

Sep 22, 2024
pulisher
Sep 22, 2024

American Century Companies Inc. Has $13.14 Million Position in United Therapeutics Co. (NASDAQ:UTHR) - Defense World

Sep 22, 2024
pulisher
Sep 21, 2024

Pacer Advisors Inc. Grows Holdings in United Therapeutics Co. (NASDAQ:UTHR) - Defense World

Sep 21, 2024
pulisher
Sep 21, 2024

Meiji Yasuda Asset Management Co Ltd. Buys 33 Shares of United Therapeutics Co. (NASDAQ:UTHR) - Defense World

Sep 21, 2024
pulisher
Sep 20, 2024

Longevity and Anti-Senescence Therapy Market Share, Size, Growth, and Forecast to 2031 - InsightAce Analytic

Sep 20, 2024
pulisher
Sep 19, 2024

Inspire Investing LLC Acquires 2,936 Shares of United Therapeutics Co. (NASDAQ:UTHR) - Defense World

Sep 19, 2024
pulisher
Sep 18, 2024

Uniti Group Inc [UNIT] stock was sold by Mudry Ronald J. at the price of US$0.11 million - Knox Daily

Sep 18, 2024
pulisher
Sep 18, 2024

1,054 Shares in United Therapeutics Co. (NASDAQ:UTHR) Bought by Choreo LLC - Defense World

Sep 18, 2024
pulisher
Sep 18, 2024

Quest Partners LLC Has $89,000 Stock Holdings in United Therapeutics Co. (NASDAQ:UTHR) - Defense World

Sep 18, 2024
pulisher
Sep 17, 2024

Liquidia Corp faces renewed legal challenge from United Therapeutics By Investing.com - Investing.com Australia

Sep 17, 2024
pulisher
Sep 17, 2024

Meeder Advisory Services Inc. Invests $36,000 in Uniti Group Inc. (NASDAQ:UNIT) - Defense World

Sep 17, 2024
pulisher
Sep 17, 2024

Unity Software Inc. (NYSE:U) Shares Bought by Daiwa Securities Group Inc. - Defense World

Sep 17, 2024
pulisher
Sep 17, 2024

Commonwealth Equity Services LLC Has $1.16 Million Position in Unity Software Inc. (NYSE:U) - Defense World

Sep 17, 2024
pulisher
Sep 16, 2024

Court rules against United Therapeutics in Liquidia case - Investing.com India

Sep 16, 2024
pulisher
Sep 15, 2024

Royal London Asset Management Ltd. Boosts Stake in Unity Software Inc. (NYSE:U) - Defense World

Sep 15, 2024
pulisher
Sep 14, 2024

694 Shares in United Therapeutics Co. (NASDAQ:UTHR) Purchased by Caprock Group LLC - Defense World

Sep 14, 2024
pulisher
Sep 04, 2024

Anti-Senescence Therapy Market is Likely to Upsurge at USD 25.16 Bn- Unity Biotechnology, OisinBiotechnologies, AgeX Therapeutics, Siwa – Daily News Mirror - Daily News Mirror

Sep 04, 2024
pulisher
Aug 31, 2024

The Top 8 Things to Know About Anti-Aging Research Right Now - upworthyscience.com

Aug 31, 2024
pulisher
Aug 20, 2024

UBX (Unity Biotechnology) Debt-to-Equity : 1.10 (As of Jun. 2024) - GuruFocus.com

Aug 20, 2024
pulisher
Aug 19, 2024

Billionaires are spending big so they — and maybe you — can live forever - MarketWatch

Aug 19, 2024
pulisher
Aug 18, 2024

Unity Biotechnology (FRA:9U90) Net-Net Working Capital : €0.01 (As of Jun. 2024) - GuruFocus.com

Aug 18, 2024
pulisher
Aug 18, 2024

UBX (Unity Biotechnology) EV-to-Revenue : (As of Aug. 18, 2024) - GuruFocus.com

Aug 18, 2024
pulisher
Aug 17, 2024

UBX (Unity Biotechnology) EPS (Basic) : $-1.74 (TTM As of Jun. 2024) - GuruFocus.com

Aug 17, 2024
pulisher
Aug 17, 2024

UBX (Unity Biotechnology) COGS-to-Revenue : 0.00 (As of Jun. 2024) - GuruFocus.com

Aug 17, 2024

Unity Biotechnology Inc (UBX) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$70.39
price down icon 0.93%
$18.42
price down icon 1.07%
$38.25
price up icon 3.56%
$367.36
price up icon 0.77%
$194.56
price up icon 0.07%
$108.23
price up icon 5.98%
자본화:     |  볼륨(24시간):